Journal list Promote Sponsor
verified SJR 0,68 · Q2 • database Scopus / SJR & Web of Science indexed
European Heart Journal, Supplement
United Kingdom · Oxford University Press
workspace_premium Q2 — Cardiology and Cardiovascular Medicine lock Subscription

European Heart Journal, Supplement

European Heart Journal, Supplement is a journal indexed in SJR in Cardiology and Cardiovascular Medicine with an H index of 43. It has an SJR impact factor of 0,68 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,68.

ISSN: 1520-765X
Publisher: Oxford University Press
Category: Cardiology and Cardiovascular Medicine
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,68 Q2
H-index 43
Acceptance rate pie_chart
33%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,68

H-index

43

Docs (year)

74

Docs 3y

377

Total refs

1876

Cites 3y

793

Citable 3y

370

Cites/Doc 2y

2.38

Ref/Doc

25.35

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable card ioverter-defibrillators

View more

Val-HeFT: changing the heart failure horizon

View more

Diabetology for cardiologists

View more

Diabetes and the heart: compromised myocardial function ? a common challenge

View more

Coronary revascularization: knife or catheter?

View more

Coronary heart disease risk in Japan ? an East/West divide?

View more

Contribution of bradykinin to the cardioprotective effects of ACE inhibitors

View more

Contrast echocardiography and medical economics: looking into the crystal ball

View more

Clinical utility of contrast echocardiography in the management of patients with acute myocardial infarction

View more

Can n-3 fatty acids provide myocardial protection by decreasing infarct size and inhibiting atherothrombosis?

View more

Bringing VALUE to LIFE

View more

Biochemistry and physiology of eicosanoid precursors in cell membranes

View more
SHOW MORE ARTICLES

AT1 receptors in atherosclerosis: biological effects including growth, angiogenesis, and apoptosis

View more

A disturbed glucose metabolic state (dysglycaemia) is a key risk factor for cardiovascular events

View more

Are diets high in omega-6 polyunsaturated fatty acids unhealthy?

View more

Antithrombin therapy, antiplatelet therapy and percutaneous coronary intervention: rationale and design of the SYNERGY trial

View more

Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: the 7250 dual defibrillator Italian Registry

View more

Antitachycardia pacing therapies to terminate atrial tachyarrhythmias: the AT500 Italian Registry

View more

Antiplatelet strategies*1

View more

Antioxidants and atherosclerosis

View more

Angiotensin-converting enzyme inhibition and endothelial dysfunction: focus on ramipril

View more

Angiotensin receptor blockers and the cardiovascular continuum: what future is indicated by recent successes?

View more

Angiotensin II overproduction: enemy of the vessel wall

View more

Alpha-linolenic acid in the prevention and treatment of coronary heart disease

View more

FAQs